EVALUATION OF N-RATIO IN SELECTING PATIENTS FOR ADJUVANT CHEMORADIOTHERAPY AFTER D2-GASTRECTOMY

@oncologician @FernandoOnco @FlorianLordick @Annals_Oncology @timpawlik @hsalvadorcr1 https://t.co/XlaoY5Q0h6 @sbco_oficial

@FernandoOnco @FrancisIgorMac1 O consider this patient as milder degrees of lymphatic spread (i.e., NR2, 10%-25%). Take a look ; its a #openaccess publication in association with the @acccancercenter upper GI team👇🏻 https://t.co/XlaoY5Q0h6